Free Trial

Sorrento Therapeutics (SRNE) Short Interest Ratio & Short Volume

Sorrento Therapeutics logo
$0.0022 +0.00 (+4.76%)
As of 03:29 PM Eastern

Sorrento Therapeutics Short Interest Data

Sorrento Therapeutics (SRNE) has a short interest of 3.52 million shares, representing 0.66% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 18.9, indicating that it would take 18.9 days of the average trading volume of 83,688 shares to cover all short positions.

Current Short Interest
3,517,500 shares
Previous Short Interest
3,517,500 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$4.57 thousand
Short Interest Ratio
18.9 Days to Cover
Last Record Date
May 31, 2025
Outstanding Shares
551,280,000 shares
Short Percent of Float
0.66%
Today's Trading Volume
24,843 shares
Average Trading Volume
83,688 shares
Today's Volume Vs. Average
30%
Short Selling Sorrento Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sorrento Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SRNE Short Interest Over Time

SRNE Days to Cover Over Time

SRNE Percentage of Float Shorted Over Time

Sorrento Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/20253,517,500 shares $4.57 thousand No Change0.7%18.9 $0.00
5/15/20253,517,500 shares $4.22 thousand -0.7%N/A13.2 $0.00
4/30/20253,543,600 shares $3.19 thousand -0.1%N/A18.6 $0.00
4/15/20253,546,100 shares $3.55 thousand 0.0%N/A35.4 $0.00
3/14/20253,548,200 shares $2.48 thousand No ChangeN/A18.7 $0.00
2/14/20253,536,100 shares $2.12 thousand -3.1%N/A31 $0.00
1/31/20253,650,700 shares $1.46 thousand +0.0%N/A22.1 $0.00
1/15/20253,649,800 shares $1.82 thousand No ChangeN/A31.6 $0.00
1/31/202364,560,000 shares $61.88 million +3.3%N/A5.8 $0.96
1/15/202362,480,000 shares $70.60 million +1.7%N/A6.1 $1.13
12/30/202261,440,000 shares $54.44 million +3.6%N/A6.3 $0.89
12/15/202259,330,000 shares $62.89 million -4.3%N/A7 $1.06
11/30/202261,990,000 shares $80.59 million +7.1%N/A8.5 $1.30
11/15/202257,910,000 shares $95.55 million -3.7%N/A8 $1.65
10/31/202260,120,000 shares $94.39 million -0.9%N/A7.9 $1.57
10/15/202260,670,000 shares $81.30 million +3.4%N/A7.7 $1.34
9/30/202258,680,000 shares $92.13 million +3.9%N/A6.9 $1.57
9/15/202256,500,000 shares $118.09 million +4.4%N/A6 $2.09
8/31/202254,110,000 shares $110.93 million -1.9%N/A5.1 $2.05
8/15/202255,130,000 shares $151.61 million -8.4%N/A5.3 $2.75
7/31/202260,200,000 shares $156.52 million +5.7%N/A5.8 $2.60
7/15/202256,970,000 shares $148.12 million -5.2%N/A5.3 $2.60
6/30/202260,070,000 shares $120.74 million +15.6%N/A5.7 $2.01
6/15/202251,960,000 shares $84.69 million -3.9%N/A5.2 $1.63
5/31/202254,080,000 shares $88.69 million +2.1%N/A5.7 $1.64
5/15/202252,970,000 shares $75.75 million -3.1%N/A5.6 $1.43
4/30/202254,660,000 shares $82.54 million +2.0%N/A6.1 $1.51
4/15/202253,580,000 shares $101.27 million +2.3%N/A5.9 $1.89
3/31/202252,390,000 shares $122.07 million +16.5%N/A6.2 $2.33
3/15/202244,990,000 shares $97.18 million -2.6%N/A5.5 $2.16
2/28/202246,210,000 shares $116.91 million +1.5%N/A6.5 $2.53
2/15/202245,520,000 shares $142.02 million -1.5%16.1%6.7 $3.12
1/31/202246,190,000 shares $159.36 million +10.7%16.3%7 $3.45
1/15/202241,720,000 shares $190.24 million -2.7%14.7%7.2 $4.56
12/31/202142,890,000 shares $199.44 million -2.9%15.2%8.1 $4.65
12/15/202144,150,000 shares $272.85 million -2.7%15.6%8.4 $6.18
11/30/202145,360,000 shares $270.35 million +0.1%16.0%9.2 $5.96
11/15/202145,320,000 shares $276.91 million -0.6%16.0%9.5 $6.11
10/29/202145,600,000 shares $312.82 million -0.9%16.3%9.7 $6.86
10/15/202146,030,000 shares $314.85 million +0.8%16.5%9.9 $6.84
Utah’s New Oil Find (Ad)

The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.

Find out why this could be the most lucrative "underground" energy story in America
9/30/202145,660,000 shares $348.39 million +6.0%16.4%9.4 $7.63
9/15/202143,070,000 shares $341.98 million -0.5%15.5%7.5 $7.94
8/31/202143,290,000 shares $389.61 million -7.2%15.7%6.9 $9.00
8/13/202146,640,000 shares $421.63 million -3.7%17.0%7.1 $9.04
7/30/202148,420,000 shares $397.53 million +0.2%17.6%7.2 $8.21
7/15/202148,330,000 shares $382.77 million -4.0%17.6%6.7 $7.92
6/30/202150,360,000 shares $487.99 million -0.9%18.4%6.6 $9.69
6/15/202150,830,000 shares $455.44 million +0.3%18.9%7 $8.96
5/28/202150,660,000 shares $380.96 million -5.2%18.8%7.1 $7.52
5/14/202153,420,000 shares $339.22 million -5.6%N/A6.4 $6.35
4/30/202156,610,000 shares $480.05 million -4.9%N/A5.4 $8.48
4/15/202159,550,000 shares $439.78 million +6.4%N/A4.1 $7.39
3/31/202155,980,000 shares $447.84 million -0.2%N/A3.4 $8.00
3/15/202156,070,000 shares $574.72 million -1.5%N/A3.2 $10.25
2/26/202156,940,000 shares $576.23 million -11.2%N/A3.1 $10.12
2/12/202164,150,000 shares $957.76 million +6.9%N/A3.4 $14.93
1/29/202160,020,000 shares $734.04 million -14.8%N/A3.1 $12.23
1/15/202170,470,000 shares $563.06 million -4.2%N/A4.2 $7.99
12/31/202073,590,000 shares $532.42 million +6.7%N/A5.1 $7.24
12/15/202068,980,000 shares $516.66 million +0.1%N/A4.1 $7.49
11/30/202068,910,000 shares $561.62 million -8.6%N/A3.3 $8.15
11/15/202075,390,000 shares $486.27 million +3.6%N/A3.4 $6.45
10/30/202072,750,000 shares $529.62 million +1.2%N/A2.6 $7.28
10/15/202071,880,000 shares $725.99 million -5.1%N/A1.8 $10.10
9/30/202075,730,000 shares $844.39 million +0.8%N/A1.8 $11.15
9/15/202075,110,000 shares $521.26 million +2.4%N/A1.7 $6.94
8/31/202073,350,000 shares $587.53 million +35.7%N/A1.8 $8.01
8/14/202054,060,000 shares $672.51 million +3.4%N/A1.3 $12.44
7/31/202052,300,000 shares $466.52 million +8.0%N/A1.1 $8.92
7/15/202048,410,000 shares $318.54 million -3.3%N/A1.3 $6.58
6/30/202050,080,000 shares $314.50 million +21.4%N/A1.5 $6.28

SRNE Short Interest - Frequently Asked Questions

What is Sorrento Therapeutics' current short interest?

Short interest is the volume of Sorrento Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 3,517,500 shares of SRNE short. 0.66% of Sorrento Therapeutics' shares are currently sold short. Learn More on Sorrento Therapeutics' current short interest.

What is a good short interest ratio for Sorrento Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRNE shares currently have a short interest ratio of 19.0. Learn More on Sorrento Therapeutics's short interest ratio.

What is a good short interest percentage for Sorrento Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.66% of Sorrento Therapeutics' floating shares are currently sold short.

How does Sorrento Therapeutics' short interest compare to its competitors?

0.66% of Sorrento Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sorrento Therapeutics: 180 Life Sciences Corp. (13.12%), Alaunos Therapeutics, Inc. (3.37%), Ensysce Biosciences, Inc. (8.15%), IM Cannabis Corp. (9.70%), Indaptus Therapeutics, Inc. (7.91%), Sonoma Pharmaceuticals, Inc. (2.90%), Mustang Bio, Inc. (3.26%), Matinas Biopharma Holdings, Inc. (1.37%), Dermata Therapeutics, Inc. (1.26%), CNS Pharmaceuticals, Inc. (3.36%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short Sorrento Therapeutics stock?

Short selling SRNE is an investing strategy that aims to generate trading profit from Sorrento Therapeutics as its price is falling. SRNE shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sorrento Therapeutics?

A short squeeze for Sorrento Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SRNE, which in turn drives the price of the stock up even further.

How often is Sorrento Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRNE, twice per month. The most recent reporting period available is May, 31 2025.




This page (NASDAQ:SRNE) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners